HOME HELP FEEDBACK HOW TO CITE ABSTRACTS ARCHIVE CME INFORMATION SEARCH Cancer Research Clinical Cancer Research Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics Molecular Cancer Research Cancer Prevention Research Cancer Prevention Journals Portal Cancer Reviews Online Annual Meeting Education Book Meeting Abstracts Online		QUICK SEARCH:   [advanced] Author: Keyword(s):

This Article Services Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Madsen, A. M. Articles by Perera, F. P. Search for Related Content PubMed Articles by Madsen, A. M. Articles by Perera, F. P.

Proffered Abstract (Oral Presentation): Diet and Cancer: Nutrigenomics

The relationship between dietary antioxidants and oxidative damage in smokers: Evidence of effect modification by lifestyle and genetic factors.

Columbia University, New York, NY; New York University School of Medicine, New York, NY

Abstract

PR-05

Several lines of evidence point to a role for vitamins in cancer prevention, though conflicting results indicate a need for more sophisticated analyses. To better understand the possible role of antioxidants in the chemoprevention of tobacco-related cancer, we measured plasma -tocopherol levels and 8-hydroxy-2'-deoxyguanosine (8OHdG) in WBC DNA of 280 smokers prior to treatment as part of a randomized clinical trial of antioxidant supplementation. We evaluated the main effects of -tocopherol on oxidative damage (8OHdG) in WBC DNA and possible effect modification by gender, obesity, GSTM1 polymorphism, and amount smoked. Adjusted and crude models were not meaningfully different, so crude results are reported. As previously reported in this study, there was a protective effect of plasma antioxidants (-tocopherol) on oxidative damage among smokers (ß = -.12, p=0.03) (Garduno et al AACR abstract 2004), restricted to a protective effect among men, with no apparent effect among women (ß (men)= -0.223, p<0.01, ß (women)= 0.025, p=0.78) (Madsen, et al AACR abstract 2005). In the current analyses, increasing plasma -tocopherol was associated with reduced oxidative damage in non-obese subjects (ßunadjusted = -0.17, p =<0.01) but not in obese subjects (ßunadjusted = 0.13, p =0.30). The interaction term was significant (ßobese x -tocopherol= .0.30, p=0.04). Increasing plasma -tocopherol was associated with reduced oxidative damage in GSTM1 non-null subjects (ßunadjusted = -0.19, p =<0.01)) but not in GSTM1 null subjects (ßunadjusted = - 0.005, p =0.95). The interaction term was suggestive (ßGSTM1 x -tocopherol= 0.18, p=0.10). Plasma -tocopherol was associated with reduced oxidative damage in light smokers (ßunadjusted = -0.19, p =<0.01) but not in heavy smokers (ßunadjusted = 0.05, p = 0.50). The interaction term was significant (ßheavy smoking x -tocopherol = 0.24, p= 0.05). The final model considered the main effects of gender, obesity, GSTM1, amount smoked, and two-way interaction terms for each variable with plasma -tocopherol on 8OHdG. Plasma -tocopherol, gender, and obesity main effects were significant at p<0.05 and the p-values for plasma--tocopherol x gender, plasma--tocopherol x obesity, plasma -tocopherol x GSTM1, plasma -tocopherol x heavy smoking, and heavy smoking terms were between p=0.05 and p=0.10. Our analyses suggest some potentially important interactions governing any protective effect of antioxidants against smoking-related oxidative damage.